Extension without change of a currently approved collection
No
Regular
02/23/2021
Requested
Previously Approved
36 Months From Approved
02/28/2021
450
450
148
148
2,137
0
The purpose of this study is to gain a
better understanding of the production of infectious aerosols by
patients with influenza, and to compare this to the levels of
biomarkers in the blood of these patients. To do this, aerosols
produced by volunteer subjects with influenza will be collected and
tested for influenza virus, and the levels of influenza
infection-associated microRNA molecules will be measured in blood
samples from these subjects. PCR assays specific to SARS-CoV-2 will
also be done to distinguish influenza patients from Covid-19
patients.
On behalf of this Federal agency, I certify that
the collection of information encompassed by this request complies
with 5 CFR 1320.9 and the related provisions of 5 CFR
1320.8(b)(3).
The following is a summary of the topics, regarding
the proposed collection of information, that the certification
covers:
(i) Why the information is being collected;
(ii) Use of information;
(iii) Burden estimate;
(iv) Nature of response (voluntary, required for a
benefit, or mandatory);
(v) Nature and extent of confidentiality; and
(vi) Need to display currently valid OMB control
number;
If you are unable to certify compliance with any of
these provisions, identify the item by leaving the box unchecked
and explain the reason in the Supporting Statement.